Defence Therapeutics Inc.
DTCFF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $39,666 | $112,380 | $70,589 | $207,369 |
| - Cash | $57 | $2,793 | $507 | $5,453 |
| + Debt | $1,746 | $1,746 | $0 | $0 |
| Enterprise Value | $41,355 | $111,333 | $70,082 | $201,916 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$14 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,676 | -$6,481 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$13,193 | -$6,763 | -$7,344 | -$2,859 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.17 | -0.2 | -0.11 |
| % Growth | -76.5% | 15% | -81.8% | – |
| Operating Cash Flow | -$4,288 | -$7,657 | -$6,044 | -$2,290 |
| Capital Expenditures | -$203 | -$66 | $0 | $0 |
| Free Cash Flow | -$4,492 | -$7,723 | -$6,044 | -$2,290 |